ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX), a biopharmaceutical company, is dedicated to in-licensing, developing and commercializing proprietary product candidates. Their key focus is on the treatment of cancer. The Company intends to enhance the performance and commercial potential of existing treatments by addressing issues related with these treatment regimens. For further information, visit the Company’s web site at www.adventrx.com.
- 18 years ago
QualityStocks
ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX)
Tags Rodman & Renshaw
Related Post
-
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights
The scale and consequences of cardiovascular disease reinforce why innovation in this space remains essential.…
-
Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Refines Atikokan Rare Earth Targets as North America Seeks More Secure REE Supply
Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. The…
-
Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Strengthens Growth Outlook with Scalable Satellite Deposit Strategy
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF)and may include paid advertising.…